APA (7th ed.) Citation

C, B., T, L., E, P., CM, F., M, W., MA, A., . . . CU, N. (2025). Polypharmacy independently predicts survival, hospitalization, and infections in patients with lymphoid cancer. HemaSphere, 9(7), e70172. https://doi.org/10.1002/hem3.70172

Chicago Style (17th ed.) Citation

C, Brieghel, Lacoppidan T, Packness E, Frederiksen CM, Werling M, Andersen MA, Poulsen CB, Rotbain EC, and Niemann CU. "Polypharmacy Independently Predicts Survival, Hospitalization, and Infections in Patients with Lymphoid Cancer." HemaSphere 9, no. 7 (2025): e70172. https://doi.org/10.1002/hem3.70172.

MLA (9th ed.) Citation

C, Brieghel, et al. "Polypharmacy Independently Predicts Survival, Hospitalization, and Infections in Patients with Lymphoid Cancer." HemaSphere, vol. 9, no. 7, 2025, p. e70172, https://doi.org/10.1002/hem3.70172.